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Objectives: Prediction of aortic hemodynamics after aortic valve replacement (AVR)
could help optimize treatment planning and improve outcomes. This study aims
to demonstrate an approach to predict postoperative maximum velocity, maximum
pressure gradient, secondary flow degree (SFD), and normalized flow displacement (NFD)
in patients receiving biological AVR.
Methods: Virtual AVR was performed for 10 patients, who received actual AVR with a
biological prosthesis. The virtual AVRs used only preoperative anatomical and 4D flow
MRI data. Subsequently, computational fluid dynamics (CFD) simulations were performed
and the abovementioned hemodynamic parameters compared between postoperative
4D flow MRI data and CFD results.
Results: For maximum velocities and pressure gradients, postoperative 4D flow MRI
data and CFD results were strongly correlated (R² = 0.75 and R² = 0.81) with low
root mean square error (0.21 m/s and 3.8 mmHg). SFD and NFD were moderately and
weakly correlated at R² = 0.44 and R² = 0.20, respectively. Flow visualization through
streamlines indicates good qualitative agreement between 4D flow MRI data and CFD
results in most cases.
Conclusion: The approach presented here seems suitable to estimate postoperative
maximum velocity and pressure gradient in patients receiving biological AVR, using only
preoperative MRI data. The workflow can be performed in a reasonable time frame and
offers a method to estimate postoperative valve prosthesis performance and to identify
patients at risk of patient-prosthesis mismatch preoperatively. Novel parameters, such
as SFD and NFD, appear to be more sensitive, and estimation seems harder. Further
workflow optimization and validation of results seems warranted.
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INTRODUCTION
Nine thousand eight hundred and twenty nine surgical isolated
aortic valve replacements (AVR) and at least 13,279 transcatheter
aortic valve implantations (TAVI) were performed in Germany in
2018. Approximately 10% of the surgical AVRs used mechanical
prostheses, with the remainder being tissue valve prostheses of
animal or human origin, while TAVI currently exclusively use
tissue valve prostheses (1). In general, the decision whether to
use a surgical or transcatheter approach as well as the choice
of prosthesis material is a clinical one and considers, among
other factors, age, life expectancy, risk of surgery, indications
and contraindications for anticoagulation, other preexisting
cardiovascular conditions, and the will of the patient.
A clinically relevant problem after AVR is patient-prosthesis
mismatch (PPM), typically classified by indexed effective orifice
area (IEOA), which is defined as the effective orifice area
(EOA) of the prosthesis in cm² normalized with the body
surface area in m². For echocardiography-based IEOA, values
above 0.85 cm²/m² are commonly classified as no PPM, values
between 0.65 cm²/m² and 0.85 cm²/m² as moderate PPM,
and values below 0.65 cm²/m² as severe PPM (2). PPM has
been shown to lead to increased morbidity and mortality as
well as decreased left ventricular mass regression following
AVR (2, 3). Mechanistically, PPM leads to increased cardiac
workload through higher-than-normal postoperative aortic valve
resistance and may require redo AVR. Other parameters to assess
the effect of prosthesis size on hemodynamics are maximum
velocity and pressure gradient across the aortic valve. Please
note that the term “pressure gradient” is used in its medical
sense, describing what is essentially a pressure difference.
Parameters quantifying aortic hemodynamics include secondary
flow degree (SFD) and normalized flow displacement (NFD).
SFD quantifies the amount of secondary flowwhile incorporating
vessel orientation, unlike helicity, for example. It has previously
been used to characterize aortic flows in the presence of valve
prostheses (4), to evaluate hemodynamic reactions to exercise (5),
and is related to wall shear stress (6). Regarding NFD, several
groups identified an association between increased NFD and
aortic dilation (7–9), while others found it to be related to left
ventricular remodeling (10). Compared to jet angle, NFD seems
to be a more reliable measure of flow eccentricity (11).
Maximum velocity and pressure gradient are typically
estimated using echocardiography in clinical settings.
While inexpensive and readily available, echocardiography-
based determination of velocities and pressure gradients is
heavily operator-dependent and only able to capture velocity
components in the direction of wave propagation. Current
research by Adriaans et al. indicates that time-resolved phase-
contrast magnetic resonance imaging (4D flowMRI) offers more
consistent measurement of velocity fields (12).
Given that the hemodynamic result of AVR can currently
only be assessed retroactively, it would be beneficial to develop
computational approaches capable of providing hemodynamic
estimates ahead of surgery, which could help in improving
therapy planning and outcomes by providing additional
information to clinicians. Computational fluid dynamics (CFD)
simulations provide a way to predict hemodynamic parameters,
and predictive modeling of diseases of the aortic, coronary,
and cerebral vasculature using CFD is a field of active research
(13–15). Some current CFD models provide diagnostic accuracy
comparable to clinical diagnostic procedures, e.g., in the
estimation of fractional flow reserve (16, 17). The publications
by Morris et al. (13) and Itatani et al. (14) also contain well-
written introductions to CFD methods used in cardiovascular
medicine, which may be helpful to readers unfamiliar with
CFD. The online version of the former publication also
contains two videos on the topic. There are various approaches
for simulating aortic valve prosthesis hemodynamics, ranging
from 2D models to spatially and temporally resolved FSI
simulations including prosthesis leaflet dynamics (18, 19).
Most studies focus on estimating specific properties, such
as thrombogenicity of mechanical bi-leaflet prostheses, or
comparing the hemodynamics of different prostheses types
(4, 20). Numerical studies on biological prostheses usually
focus on transcatheter implantation and specific aspects of this
intervention type, e.g., the predictability of paravalvular leakage
(21). In contrast, this study tries to provide a method capable of
estimating the immediate hemodynamic outcome after AVR in a
homogenous cohort.
Given their frequent clinical use and the fact that they
exhibit a natural orientation during implantation, we decided to
focus on surgically implanted, biological aortic valve prostheses.
This study aims to provide a method capable of estimating
clinically relevant hemodynamic aortic valve parameters in
patients receiving surgical AVR with a biological valve prosthesis,
using only information available preoperatively. This was done
by using preoperative MRI data of the patients to reconstruct the
geometry of the aorta and perform virtual AVR. Subsequently,
CFD simulations were performed on the virtual AVR geometries
and the relevant hemodynamic parameters were computed from
the CFD results. The CFD-based hemodynamic parameters
were then compared with the same parameters computed from
postoperative 4D flow MRI data. We decided to compare
CFD against 4D flow MRI instead of echocardiography due to
the increased reproducibility and consistency of 4D flow MRI
mentioned above.
PATIENTS AND METHODS
The data used in this study was acquired during the SMART
study (ClinicalTrials.gov identifier NCT03172338, GermanHeart
Center Berlin, ethics committee approval ID EA2/133/14,
10.12.2015). Written informed consent was obtained from
all patients.
Magnetic Resonance Imaging Acquisition
We used data from 10 patients, who underwent surgical AVR
at the German Heart Center Berlin. Patient characteristics are
summarized in Table 1. All patients received a Carpentier-
Edwards PerimountMagna Ease aortic valve prosthesis (Edwards
Lifesciences, Irvine, USA). Pre- and post-operative anatomical
MRI imaging was performed on a 1.5 T Achieva MRI scanner
(Philips Medical Systems, Hamburg, Germany) with a typical
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TABLE 1 | Patient characteristics.
Characteristic Median (range) or ratio
Age [years] 64 (57–72)
Sex [female] 3/10
Weight [kg] 95 (70–110)
Height [cm] 182 (164–198)
Body surface area [m²] 2.19 (1.80–2.42)
Aortic valve stenosis, preoperative 10/10
Aortic valve insufficiency, preoperative 4/10 (all classified as mild)
reconstructed voxel size of 0.80 × 0.80 × 2.00mm. Anatomical
imaging data was obtained during diastole. 4D flowMRI data was
reconstructed at a typical voxel size of 2.80 × 2.25 × 2.25mm
with a temporal resolution of 25 phases per cardiac cycle.
Based on the anatomical imaging data, the left ventricular
outflow tract (LVOT), the thoracic aorta, and the most proximal
parts of the brachiocephalic, left common carotid, and left
subclavian artery were manually segmented using ZIBAmira
(version 2015.28, Zuse Institute Berlin, Berlin, Germany).
Additionally, the nadirs and commissures of the native aortic
valve, the ostia and most proximal parts of the coronary arteries,
the anterior leaflet of the mitral valve, and the native aortic valve
were segmented approximatively to aid orientation during virtual
intervention (Figures 1A,B).
Computational Fluid Dynamics
Geometries of the Perimount Magna Ease prosthesis and its
opened leaflets were kindly provided to us by Claudio Capelli
(Institute of Cardiovascular Science, University College London,
London, UK). A model of the opened prosthesis was then
constructed from the prosthesis frame and leaflet models
(Figure 1C); the resulting model of the open prosthesis was
subsequently scaled to approximate the different sizes offered
by the manufacturer (19–29mm in 2mm intervals). Virtual
interventions consisted of positioning a 3D model of an opened
Perimount Magna Ease prosthesis in the preoperative vessel
geometry, subsequent intersection of the prosthesis and vessel
geometries, and cleanup of the resulting geometry using STAR-
CCM+ (version 13.02, Siemens Digital Industries Software,
Plano, USA) and MeshLab (version 2016.12, Visual Computing
Lab, Istituto di Scienza e Tecnologie dell’Informazione, Pisa,
Italy) to produce a manifold and topologically correct surface
geometry (Figure 1D). Choice of prosthesis size and placement
was performed by a cardiac surgeon with experience in surgical
AVR. In cases where the prosthesis size virtually implanted by
the surgeon was different from the one used during the actual
surgery, a second geometry was created using the prosthesis size
used during surgery, placed in the same position as the first
prosthesis. Table 2 shows the prosthesis sizes for all patients.
The resulting geometry was then used to perform
computational fluid dynamics (CFD) simulations using STAR-
CCM+. Peak systolic, stationary boundary conditions were set
using 4D flow MRI profiles for the LVOT inlet (Figure 1E) and
4D flow MRI flow rates for the descending aorta outlet. Table 2
shows inlet flow rates and Reynolds numbers for all patients.
Reynolds numbers were calculated at the narrowest part of the
prostheses using the rheological model’s infinite shear viscosity
µ∞ = 0.0035 Pa·s. Flow profiles were extracted from the 4D flow
MRI data with MEVISFlow (version 11.0, Fraunhofer MEVIS,
Bremen, Germany). The remainder of the flow was distributed
among the branching vessels of the aortic arch using Murray’s
law and requiring that the brachiocephalic artery receives the
same flow rate as the left common carotid and left subclavian
artery together. Inlet turbulence intensity was set at 5%, similar
to values measured by Isaaz et al. in vivo (22). An implicit finite
volume solver using a shear stress transport k-ω turbulence
model was used to solve the Navier–Stokes and continuity
equations, which describe the flow field. Blood was modeled as a
constant density (1,050 kg/m3) Carreau–Yasuda fluid (zero shear
viscosity µ0 = 0.16 Pa·s, infinite shear viscosity µ∞ = 0.0035
Pa·s, power constant n = 0.2128, transition parameter a = 0.64,
relaxation parameter λ = 8.2 s); for a discussion of viscosity
models in aortic CFD, refer to Karimi et al. (23). The boundaries
of the flow domain, i.e., the aortic wall and the valve prosthesis,
were modeled as rigid. Aortic geometries were modeled in their
diastolic state. Based on a convergence study, the base mesh size
was chosen at 0.5mm, at and below which mesh resolution did
not relevantly influence the evaluated hemodynamic parameters.
A blended wall function approach was used for wall treatment.
Cell counts varied from 2.85 to 5.09 million per geometry,
depending on the physical size of the computational domain.
Simulations were performed on a Xeon E5-2630 v4 CPU (Intel,
Santa Clara, USA); the modeling workflow took approximately a
week per patient, including segmentation, geometry preparation,
virtual intervention, and simulation.
Hemodynamic Parameters
Evaluated hemodynamic parameters were vmax (maximum flow
velocity in the valve jet), dpmax (maximum pressure gradient
across the aortic valve), SFD (secondary flow degree), and NFD
(normalized flow displacement). dpmax of 4D flowMRI and CFD
data was estimated from vmax using the commonly used, strongly
simplified version of the Bernoulli equation dpmax = 4·vmax²
with the units of vmax being m/s and the unit of dpmax being
mmHg (24). Note that while this estimate and its derivatives
are commonly and successfully used in clinical decision making
and guidelines, they do not accurately reflect the actual physical
pressure drop across the aortic valve. For a discussion of pressure
recovery in aortic stenoses and prostheses, refer, for example, to
Baumgartner et al. (25) or Dohmen et al. (26). SFD and NFD
are scalar parameters calculated from three vessel cross sections,
which were placed at the sinotubular junction, directly proximal
of the brachiocephalic artery and in the middle between the two
previous sections (i.e., in the middle of the ascending aorta). SFD
is defined as the mean in-plane velocity divided by the mean
through-plane velocity. NFD is defined as the flow displacement
normalized by the vessel diameter, with the flow displacement
being the distance between the vessel center and the center of
the flow. We used the hydraulic vessel diameter (4 times cross-
sectional area divided by perimeter) for normalization. We also
estimated MRI- and CFD-based IEOA for each patient. EOA was
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FIGURE 1 | Relevant steps of the virtual intervention process. (A) Example of virtual operating field, dorsal view. (B) Example of the virtual operating field, oblique view,
ascending aorta and aortic arch removed. (C) 3D model of the open 23mm valve prosthesis. (D) Example of the final CFD domain used for simulation. (E) 4D flow
MRI inlet profile for CFD simulations. Note that the images are not from the same patient.






















I 23 23 354 6,997
II 29 27 430 7,240
III 25 25 394 7,164
IV 25 23 539 10,653
V 25 23 367 7,253
VI 25 23 235 4,645
VII 27 23 407 8,044
VIII 25 21 296 6,407
IX 25 25 412 7,491
X 23 25 464 8,437
estimated using the respective dpmax and the EOA equation used
by Weese et al. (27). The EOA estimate was then normalized
using patient body surface area, to obtain an estimate of IEOA.
Additionally, streamlines were calculated to visualize the flows
and allow qualitative comparison. Parameters were extracted,
calculated, and visualized using MEVISFlow, ZIBAmira and
MATLAB (version 2017b, MathWorks, Natick, USA).
Using these hemodynamic parameters, CFD flow fields were
compared against postoperative 4D flowMRI data of the patients.
To reduce bias, evaluation of vmax and placement of the cross
sections used to compute SFD and NFD were done by different
authors for the CFD and MRI data. The author analyzing CFD
data did not have access to the post-interventional MRI data, and
the authors analyzing the post-interventional MRI data did not
have access to the CFD data. Note that there are 2 CFD data
sets for the cases, for which the prosthesis size chosen during the
virtual intervention (index vi) did not match the one used during
actual surgery (index as), one for each of the two sizes.
Statistical analysis was performed for vmax, dpmax, SFD,
NFD, IEOAmri, and IEOAas, using MATLAB. Since only simple
linear regression was performed, the unadjusted coefficient
of determination R², which in this case is the square of
Pearson’s r, was used. Estimates of parameters are indicated
using the hat operator, e.g., v̂max. Where specified, the use of
median and interquartile range as measures of central tendency
and dispersion was based on inspection of histograms of the
underlying data.
RESULTS
In order to identify the hemodynamic results, the following
indices are used: mri for the results derived from postoperative
4D flow MRI, vi for the results of the CFD simulations using
the prosthesis size determined by the surgeon during virtual
intervention, and as for the results of the CFD simulations using
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TABLE 3 | 4D flow MRI- and CFD-based estimated indexed effective orifice areas
(IEOA) for all patients.











the prosthesis size used during the actual surgery performed on
the patient. Given the number of patients, we decided to follow a
descriptive statistics approach.
Choice of Prosthesis Size and IEOA
Table 2 summarizes the prosthesis sizes used during virtual
interventions and actual surgeries, while Table 3 shows estimated
IEOAas for the actual size CFD simulations and IEOAmri
for the postoperative 4D flow MRI data. We also calculated
the coefficient of determination for linear regression between
IEOAas and IEOAmri, which was R² = 0.52. For three patients,
the prosthesis sizes chosen during virtual intervention and
actual surgery were identical. The mean absolute error between
the prosthesis size chosen during virtual intervention and
the prosthesis size actually used was 1.8mm with the virtual
interventions using a larger prosthesis size on average.
Pressure Gradients and Maximum
Velocities
Figure 2 shows scatter and linear regression plots for vmax and
dpmax. Coefficient of determination (R²), root mean square error
(RMSE), and regression equation for vmax,mri vs. vmax,vi were R²
= 0.69, RMSE = 0.24 m/s, and v̂max,mri = 0.8478·vmax,vi+0.7887
m/s, while they were R²= 0.75, RMSE= 0.21 m/s, and v̂max,mri =
0.9073·vmax,as+0.5787 m/s for vmax,mri vs. vmax,as. Median values
(interquartile range) of vmax were 2.1 m/s (0.3 m/s), 1.7 m/s
(0.6 m/s), and 1.7 m/s (0.4 m/s) for vmax,mri, vmax,vi, and vmax,as,
respectively. Similarly, the statistics were R² = 0.73, RMSE =
4.5 mmHg, and dp̂max,mri = 1.227·dpmax,vi+5.601 mmHg for
dpmax,mri vs. dpmax,vi, with R² = 0.81, RMSE = 3.8 mmHg,
and dp̂max,mri = 1.175·dpmax,as+4.281 mmHg for dpmax,mri vs.
dpmax,as. Median values (interquartile range) of dpmax were 18
mmHg (5 mmHg), 11 mmHg (8 mmHg), and 12 mmHg (6
mmHg) for dpmax,mri, dpmax,vi, and dpmax,as, respectively.
Quantitative Description of Hemodynamics
Linear regression results for SFD and NFD are shown in Table 4;
the coefficients of determination for SFD andNFDwere generally
lower than for vmax and dpmax. Median values (interquartile
range) of SFD over all cross sections were 0.70 (0.57), 0.88
(0.56), and 0.95 (0.51) for SFDmri, SFDvi, and SFDas, respectively.
Median values (interquartile range) of NFD over all cross sections
were 0.072 (0.090), 0.148 (0.066), and 0.155 (0.062) for NFDmri,
NFDvi, and NFDas, respectively. Additionally, Table 4 shows
median values and interquartile ranges of SFD and NFD for each
cross section individually. Figure 2 contains scatter and linear
regression plots for SFD and NFD, color- and marker-coded by
cross-section location.
Qualitative Description of Hemodynamics
For hemodynamic visualization, Figure 3 shows streamlines for
all patients. For most patients, the MRI- and CFD-based flow
fields agree well, with the main flow features and velocities
being comparable. In general, the locations of regions with very
low velocities close to stagnation are very similar between both
methods. In several patients, these regions are located close to
the concave curvature of the ascending aorta (e.g., patients III,
VI, VII, and VIII). In patient III, a similar region is identified
in the descending aorta by both methods. The orientation of the
jet passing through the valve prosthesis, and thus the orientation
of the valve prosthesis itself, is also comparable between both
methods. Only in patients I and III can a slight deviation between
the simulation using the actual size and the MRI measurements
be observed.
However, some relevant deviations between measured and
calculated hemodynamics can be found. In patient VI, a flow
acceleration in the proximal descending aorta is observed in
the MRI data. This flow feature is not nearly as pronounced
in the CFD data, even though the vessel contours agree well in
that region. In the MRI data of patient II, high velocities are
observed immediately downstream of the valve prosthesis with a
subsequent strong deceleration proximal to the aortic arch. This
flow pattern is not found in the CFD data.
The simulations using prosthesis sizes chosen during virtual
intervention (CFDvi) tend to show lower flow velocities than the
simulations using prosthesis sizes chosen during actual surgery
(CFDas). The visualization also shows that flow patterns are quite
similar between CFDvi and CFDas.
DISCUSSION
R² and RMSE indicate good agreement between MRI- and
CFD-based values of vmax and dpmax. This suggests that
postoperative maximum pressure gradients and velocities can
be estimated reasonably well using the current CFD model.
The correlation between MRI-based and CFD-based values was
generally stronger for the simulations using the actual prosthesis
size over the simulations using the prosthesis size chosen during
virtual intervention. As the virtual intervention prosthesis sizes
were, on average, off by about one size, this observation can most
likely be attributed to the mismatch between actual and virtual
prosthesis size. Simulations using the prosthesis size chosen
during virtual intervention tend to show lower flow velocities,
which seems plausible given their, on average, larger orifice areas.
The difference in prosthesis size is likely caused by the virtual
intervention providing no sizing mechanism similar to the use
of a sizing instrument during actual surgeries. This seems to
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FIGURE 2 | Scatter and linear regression plots for vmax, dpmax, SFD, and NFD. (A) vmax,vi vs. vmax,mri. (B) dpmax,vi vs. dpmax,mri. (C) SFDvi vs. SFDmri. (D) NFDvi vs.
NFDmri. (E) vmax,as vs. vmax,mri. (F) dpmax,as vs. dpmax,mri. (G) SFDas vs. SFDmri. (H) NFDas vs. NFDmri. Index mri identifies 4D flow MRI results, vi identifies CFD results
using virtual intervention prosthesis size, and as identifies CFD results using actual surgery prosthesis size. For SFD and NFD, least-square lines are plotted separately
for each cross section with STJ being the cross section at the sinotubular junction, MAA being the cross section in the middle of the ascending aorta, and PBA being
the cross section directly proximal to the brachiocephalic artery.
lead to overestimation of the space available for implantation.
Furthermore, the suture ringmay in vivo assume a shape different
from the 3D prosthesis model. In practice, the issue of correctly
predicting prosthesis size could easily be overcome by being
mindful of the tendency to overestimate prosthesis size as well
as by performing simulations with multiple possible prosthesis
sizes ahead of surgery. This would ensure that the surgeon would
preoperatively have CFD results available for all plausible sizes,
effectively removing the problem of having to choose the correct
prosthesis size.
The underestimation of vmax and dpmax by CFD might
partially be caused by the CFD simulations being based on
preoperative MRI profiles. After valve replacement, peak systolic
flow likely increases due to reduced valvular resistance, which
in turn might explain the relatively higher vmax and dpmax in
the MRI data. Additionally, postoperative prosthesis opening
might be subtotal compared to the idealized, fully open prosthesis
model used for CFD, resulting in higher vmax and dpmax.
IEOAmri and IEOAas were moderately correlated, indicating
that the predicting postoperative IEOA still poses some challenge.
While IEOA is a relevant factor, current recommendations also
emphasize the importance of flow velocity and pressure gradient
in assessing hemodynamic prosthesis performance (28). These
parameters exhibit fairly low RMSE of 0.21 m/s and 3.8 mmHg,
respectively. By considering all parameters together, one should
therefore be able to arrive at a reasonably accurate estimate of
postoperative prosthesis performance.
While good agreement between real and virtual intervention
was observed for the pressure gradient and the maximum
velocity, SFD and NFD featured lower R² and worse RMSE. The
latter parameters describe the spatially resolved hemodynamics.
Even though 4D flow MRI and the velocity information
calculated using CFD were registered, to ensure identical
orientation of the evaluation cross sections used for both data
sets, minor deviations might still be present. Furthermore, SFD
and NFD are likely more susceptible to the segmentation of
the patient-specific geometry as well as the orientation of the
valve prosthesis. Especially the latter parameter will directly affect
NFD, as the orientation of the valve prosthesis will directly
affect the orientation of its jet-like outflow. As only preoperative
information was used for the virtual intervention, the orientation
of the virtual and real prosthesis might differ. There might also
be some differences between pre- and postoperative anatomies,
which could have an influence on SFD/NFD. While we focused
on patients receiving isolated AVR, there might still be small
anatomical changes associated with surgery and MRI image
acquisition, e.g., due to sutures, mobilization of anatomical
structures, the prosthesis itself, or subtly different patient posture
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TABLE 4 | Median value, interquartile range (IQR), and linear regression for SFD and NFD.
Parameter Median (IQR) for mri Median (IQR) for vi Median (IQR) for as R² mri vs. vi R² mri vs. as RMSE mri vs. vi RMSE mri vs. as
SFD all cross sections 0.70 (0.57) 0.88 (0.56) 0.95 (0.51) 0.38 0.44 0.39 0.37
SFD sinotubular junction 0.89 (0.49) 0.99 (0.45) 1.08 (0.21) 0.25 0.16 0.32 0.33
SFD middle of ascending aorta 0.87 (0.52) 0.99 (0.60) 1.00 (0.56) 0.27 0.46 0.56 0.48
SFD proximal to brachiocephalic
artery
0.48 (0.28) 0.77 (0.32) 0.78 (0.49) 0.49 0.53 0.24 0.23
NFD all cross sections 0.072 (0.09) 0.148 (0.066) 0.155 (0.062) 0.23 0.20 0.048 0.049
NFD sinotubular junction 0.065 (0.05) 0.122 (0.040) 0.122 (0.030) 0.08 0.10 0.044 0.044
NFD middle of ascending aorta 0.144 (0.049) 0.192 (0.058) 0.189 (0.054) 0.10 0.10 0.038 0.038
NFD proximal to brachiocephalic
artery
0.037 (0.036) 0.141 (0.048) 0.160 (0.054) 0.30 0.20 0.020 0.021
Index mri identifies 4D flow MRI results, vi identifies CFD results using virtual intervention prosthesis size, and as identifies CFD results using actual surgery prosthesis size.
Coefficients of determination (R²) and root mean square error (RMSE) are for linear regression between MRI- and CFD-based values; all regressions use the CFD-based values as
the independent variable.
during postoperative MRI. Another factor possibly influencing
SFD and NFD calculation is the use of a RANS-based turbulence
model to keep computation time reasonable. RANS-based
turbulence models cannot capture all temporal and spatial scales
of the flow, which may lead to subtle differences in SFD and
NFD. Additionally, the 4D flow MRI resolution was significantly
lower than the resolution of the CFD mesh, meaning that some
flow scales included in the calculation of CFD-based SFD/NFD
might not have been included in the calculation of MRI-based
SFD/NFD. Finally, the inlet velocity profiles were measured
before AVR and they might subsequently change. It has been
shown that the inlet profile can affect the flow distal to the valve
prosthesis (6).
Another point regarding NFD is that it has previously been
shown to correlate with aortic dilation in patients with high
NFD values secondary to strongly eccentric flow, in turn caused
by bicuspid aortic valve morphology (7, 8). Burris et al. found
an NFD cutoff value of 0.2, above which the aortic growth
rate increased significantly in their study (8). Such high values
of NFD did rarely occur in our patients, likely due to them
receiving the prostheses as well as none of them exhibiting
relevant ascending aorta dilation. It is therefore conceivable
that the correlation between MRI- and CFD-based NFD would
be stronger in patients with higher NFD, in whom constant
modeling errors would be relatively smaller.
The MRI- and CFD-based streamlines are quite similar
for most patients. In most cases, relevant flow features,
such as recirculation zones and the location of prosthesis jet
impingement on the aortic wall, were comparable. Velocity
magnitudes were mostly similar. The existing small differences
could have potentially been caused by segmentation differences,
subtly different prosthesis placement, and inertial effects.
The present study demonstrates a method to estimate
postoperative hemodynamic parameters after AVR using only
preoperative data. Unlikemore complex CFDmodels, whichmay
include unsteady FSI simulations of prosthesis hemodynamics
(19, 20), the approach presented in this study uses a less
complex model, including rigid walls and stationary boundary
conditions. While this means that hemodynamic parameters
cannot be evaluated in a time-resolved manner and also neglects
dynamic effects, it reduces modeling and computation time
and avoids having to estimate unknown elastic properties of
the aorta and valve prosthesis. The present method is less
well-suited for understanding complex flow phenomena and
does not allow analysis of certain features, such as valve
prosthesis opening and closing. The workflow can, however,
be performed in a clinically reasonable time frame and offers
good robustness, which is important for clinical applicability
and direct comparison against postoperative 4D flow MRI
data. Novel aspects of the present study include the model
being solely based on preoperative data, its results being
directly compared to postoperative 4D flow MRI data and the
virtual intervention being performed by a cardiac surgeon with
experience in AVR.
Limitations
The model used in this study uses a quasi-steady approach to
predict the peak systolic hemodynamics after AVR. The aorta
and the leaflets of the aortic valve prosthesis were modeled
as rigid. Additionally, to evaluate the predictive capabilities of
this model, only patient data acquired before AVR was used.
These limitations might partially explain the weak-to-moderate
correlations of SFD and NFD. For example, replacement of the
diseased valve might affect myocardial function and thus the
LVOT flow profile as well as peak systolic flow rates. Additionally,
the surgical implantation will result in small changes to the
anatomy of the ascending aorta. There are currently no models
to predict either the change in ventricular hemodynamics or the
postoperative anatomy. However, the changes in anatomy seem
to be limited, as the vessel contours of the ascending aorta in
agree well in all cases.
While simulation of the dynamic behavior of aortic valve
prostheses is technically feasible, such simulations not only are
associated with higher computational costs but also require
estimation of patient-specific material properties. Furthermore,
either the transient LVOT inflow profile must be measured, or
the left ventricular contraction must be modeled. All these steps
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FIGURE 3 | Streamlines of MRI and CFD data. CFDvi denotes simulations using the prosthesis size chosen during virtual intervention, while CFDas denotes
simulations using the prosthesis size chosen during actual surgery. Streamlines are color-coded by velocity, right ventrolateral view. Note that the MRI-based
streamlines begin at the prosthesis, while the CFD-based streamlines also extend into part of the left ventricle.
introduce additional uncertainty due to model assumptions and
additional measurements.
CONCLUSION
The results demonstrate that, using the approach presented
in this study, MRI-based maximum pressure gradients and
velocities across biological aortic valve prostheses can be
estimated reasonably well from CFD simulations based only
on preoperative MRI and clinical patient data. The approach
could potentially be used to identify which prosthesis sizes
are likely to put individual patients at risk of increased
postoperative pressure gradient ahead of surgery and to
estimate postoperative prosthesis performance. The workflow
is comparatively inexpensive computationally and can be
performed within a clinically reasonable time frame. Regarding
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novel and sensitive hemodynamic parameters like SFD or NFD,
further work needs to be undertaken to accurately estimate them
in the patient collective described here.
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